Treatment of gastrointestinal and renal adenocarcinomas with interferon-alpha.
Treatment of gastrointestinal and renal adenocarcinomas with interferon-alpha.
复制标题
用干扰素-α治疗胃肠道和肾腺癌。
DOI:
10.1007/bf02174204
复制
发表时间:
1992
期刊:
影响因子:
--
通讯作者:
Ozer,H
中科院分区:
文献类型:
--
作者:
Meadows,LM;Lindley,C;Ozer,H
Treatment of adenocarcinomas with interferon-alpha as a single agent has been disappointing. Recent efforts have focused on the combination of interferon with cytotoxic drugs such as 5-fluorouracil. A number of postulated mechanisms can explain synergistic interactions between 5-fluorouracil and interferon-alpha, including interaction with pyrimidine pathways, and alteration of drug metabolism. Previous studies in colorectal cancer, using 5-fluorouracil and interferon-alpha are reviewed, suggesting that the combination is more active than 5-fluorouracil alone. In renal cell carcinoma, the literature is reviewed, suggesting that daily interferon is the most efficacious schedule; preliminary data suggest that addition of 5-fluorouracil to interferon-alpha can double the expected response rate of 16% achieved by interferon-alpha alone.
登录
查看更多内容
影响因子:
14.9
作者:
E. Trip;M. Smith
通讯作者:
M. Smith
影响因子:
64.5
作者:
R. Scheller;F. Costantini;M. Kozlowski;R. Britten;E. Davidson
通讯作者:
E. Davidson
影响因子:
2.7
作者:
M. Dworkin;I. Dawid
通讯作者:
I. Dawid
影响因子:
3.5
作者:
Hu Nien;J. Messing
通讯作者:
J. Messing
影响因子:
2.9
作者:
BRUNK, CF;JONES, KC;JAMES, TW
通讯作者:
JAMES, TW